Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sasha M. Lupichuk is active.

Publication


Featured researches published by Sasha M. Lupichuk.


Cancer Epidemiology, Biomarkers & Prevention | 2016

Effects of a Structured Exercise Program on Physical Activity and Fitness in Colon Cancer Survivors: One Year Feasibility Results from the CHALLENGE Trial

Kerry S. Courneya; Janette Vardy; Christopher J. O'Callaghan; Christine M. Friedenreich; Kristin L. Campbell; Harry Prapavessis; Jennifer J. Crawford; Patti O'Brien; Haryana M. Dhillon; Derek J. Jonker; Neil Chua; Sasha M. Lupichuk; Michael S. Sanatani; Sharlene Gill; Ralph M. Meyer; Stephen Begbie; Tony Bonaventura; Matthew Burge; Jane Turner; Dongsheng Tu; Christopher M. Booth

Background: There is strong interest in testing lifestyle interventions to improve cancer outcomes; however, the optimal methods for achieving behavior change in large-scale pragmatic trials are unknown. Here, we report the 1-year feasibility results for exercise behavior change in the Canadian Cancer Trials Group CO.21 (CHALLENGE) Trial. Methods: Between 2009 and 2014, 273 high-risk stage II and III colon cancer survivors from 42 centers in Canada and Australia were randomized to a structured exercise program (SEP; n = 136) or health education materials (HEM; n = 137). The primary feasibility outcome in a prespecified interim analysis was a difference between randomized groups of ≥5 metabolic equivalent task (MET)-hours/week in self-reported recreational physical activity (PA) after at least 250 participants reached the 1-year follow-up. Secondary outcomes included health-related fitness. Results: The SEP group reported an increase in recreational PA of 15.6 MET-hours/week compared with 5.1 MET-hours/week in the HEM group [mean difference = +10.5; 95% confidence interval (CI) = +3.1–+17.9; P = 0.002]. The SEP group also improved relative to the HEM group in predicted VO2max (P = 0.068), 6-minute walk (P < 0.001), 30-second chair stand (P < 0.001), 8-foot up-and-go (P = 0.004), and sit-and-reach (P = 0.08). Conclusions: The behavior change intervention in the CHALLENGE Trial produced a substantial increase in self-reported recreational PA that met the feasibility criterion for trial continuation, resulted in objective fitness improvements, and is consistent with the amount of PA associated with improved colon cancer outcomes in observational studies. Impact: The CHALLENGE Trial is poised to determine the causal effects of PA on colon cancer outcomes. Cancer Epidemiol Biomarkers Prev; 25(6); 969–77. ©2016 AACR.


Journal of Clinical Oncology | 2013

Assessing the need for a nurse-led breast cancer telephone follow-up clinic in Alberta, Canada.

Sasha M. Lupichuk; Cindy Railton; Jenny J. Ko; Jennifer McCormick; Lihong Zhong; Anil A. Joy; Barbara Walley; Janine Giese-Davis

111 Background: Routine follow-up of breast cancer (BC) patients is largely transferred to primary care due to limited tertiary care resources and evidence supporting the acceptability and safety of this approach. It is unknown how BC survivors are faring in the community with treatment and surveillance goals, and if there is an unmet need for access to specialist care. Objectives of this cross-sectional study of BC survivors were to examine: concordance with endocrine therapy and follow-up recommendations; perceived need for help with achieving these recommendations; and, perceived need for a telephone follow-up clinic. METHODS Eligible participants were women with stage I-III BC diagnosed June 2006-September 2009 who had been seen in consultation at a tertiary cancer centre (TCC) in Alberta, Canada. 960 potentially eligible women were invited to participate via mail-out from the Alberta Cancer Registry. Consenting participants completed a structured telephone interview. Further patient, disease, endocrine therapy and surveillance data were obtained from the electronic chart and pharmacy databases. RESULTS 240 participants completed the telephone interview. 68.8% had been discharged from a TCC. 87.1% reported having had a clinical breast examination, and 97.1% with remaining breast tissue reported having had a surveillance mammogram within the past year. Concordance with endocrine therapy varied between pharmacy dispensing records (95.4%) versus self-report (82.0%). Top participant-identified gaps in post-treatment services were: side effect management, achieving body weight and physical activity goals, psychosocial health, and sexual health. 71.7% of participants reported that they would have used a telephone follow-up clinic. Factors associated with telephone follow-up clinic use included younger age, no endocrine therapy, fatigue, and non-urban residence. CONCLUSIONS Concordance with measurable follow-up goals (exam, mammography, endocrine therapy) was better than expected. Despite this, interest in a nurse-led BC telephone follow-up clinic was high. Perceived needs included management of symptoms plus support for life-style behavior change.


Blood | 2003

Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation

Chandini M. Thirukkumaran; Joanne Luider; Douglas A. Stewart; Tina Cheng; Sasha M. Lupichuk; Michael J. Nodwell; James A. Russell; Iwona A. Auer; Donald Morris


Current Oncology | 2009

Optimal use of taxanes in metastatic breast cancer

Karen M. King; Sasha M. Lupichuk; Lubna Baig; Marc Webster; Sanraj Basi; Darlene Whyte; Serena Rix


Breast Cancer Research and Treatment | 2016

Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer.

Daniel Rayson; Sasha M. Lupichuk; Kylea Potvin; Susan Dent; Tamara Shenkier; Sukhbinder Dhesy-Thind; Susan Ellard; Catherine Prady; Muhammad Salim; Patricia Farmer; Ghasson Allo; Ming-Sound Tsao; Alison L. Allan; Olga Ludkovski; Maria Bonomi; Dongsheng Tu; Linda Hagerman; Rachel Anne Goodwin; Elizabeth Eisenhauer; Penelope Bradbury


Journal of The National Comprehensive Cancer Network | 2015

Discharge to Primary Care for Survivorship Follow-Up: How Are Patients With Early-Stage Breast Cancer Faring?

Cindy Railton; Sasha M. Lupichuk; Jennifer McCormick; Lihong Zhong; Jenny J. Ko; Barbara Walley; Anil A. Joy; Janine Giese-Davis


Journal of Clinical Oncology | 2017

Adjustments in relative dose intensity (RDI) for FECD chemotherapy in breast cancer: A population analysis.

Zachary William Neil Veitch; Omar Farooq Khan; Derek Tilley; Kostaras Xanthoula; Patricia A. Tang; Karen M. King; Sasha M. Lupichuk


Journal of Clinical Oncology | 2017

A phase II study of foretinib in triple-negative, recurrent/metastatic breast cancer: NCIC CTG trial IND.197 (NCT01147484).

Daniel Rayson; Sasha M. Lupichuk; Stephen Chia; Kylea Potvin; Susan Dent; Ming-Sound Tsao; Catherine Prady; Susan Ellard; Muhammad Salim; Ghassan Allo; Olga Ludkovski; Rachel Anne Goodwin; Nancy Wainman; Wendy Walsh; Pat Farmer; Elizabeth Eisenhauer


Journal of Clinical Oncology | 2018

Comparison of clinical characteristics and survival of metastatic breast cancer patients in United States according to insurance status as compared to outcomes in Canada.

Adriana Reis Brandao Matutino; Allan Andresson Lima Pereira; Elizabeth Kornaga; Sasha M. Lupichuk; Sunil Verma


European Journal of Public Health | 2018

Premature mortality due to breast cancer among Canadian women: an analysis of a 30-year period from 1980 through 2010

Truong-Minh Pham; Khokan Sikdar; Bethany Kaposhi; Sasha M. Lupichuk; Huiming Yang; Lorraine Shack

Collaboration


Dive into the Sasha M. Lupichuk's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anil A. Joy

Cross Cancer Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel Rayson

Queen Elizabeth II Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar

Derek J. Jonker

Ottawa Hospital Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Harry Prapavessis

University of Western Ontario

View shared research outputs
Researchain Logo
Decentralizing Knowledge